Powder: -20°C for 3 years | In solvent: -80°C for 1 year
K00135 (IMIDAZOPYRIDAZIN 1) is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.
説明 | K00135 (IMIDAZOPYRIDAZIN 1) is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics. |
In vitro | K00135 dose-dependently impairs the survival of murine Ba/F3 cells that have been rendered cytokine independent by overexpression of human PIMs. K00135 impairs survival and clonogenic growth of a panel of human acute leukemia cells. Exposure of K00135 significantly suppresses in vitro growth of leukemic blasts from five acute myelogenous leukemia patients but not of normal umbilical cord blood mononuclear cells[3]. |
別名 | K-00135, Imidazol[1,2-b]pyridazine 1, K 00135, IMIDAZOPYRIDAZIN 1 |
分子量 | 306.36 |
分子式 | C18H18N4O |
CAS No. | 869650-21-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.4 mg/mL (14.36 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
K00135 869650-21-5 Chromatin/Epigenetic JAK/STAT signaling Pim K-00135 Imidazol[1,2-b]pyridazine 1 K 00135 IMIDAZOPYRIDAZIN 1 Inhibitor inhibitor inhibit